Pakistan · Delayed Price · Currency is PKR IBL HealthCare Statistics
Total Valuation
IBL HealthCare has a market cap or net worth of PKR 4.16 billion. The enterprise value is 3.46 billion.
| Market Cap | 4.16B |
| Enterprise Value | 3.46B |
Important Dates
The last earnings date was Wednesday, September 23, 2026.
| Earnings Date | Sep 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IBL HealthCare has 98.53 million shares outstanding. The number of shares has decreased by -0.13% in one year.
| Current Share Class | 98.53M |
| Shares Outstanding | 98.53M |
| Shares Change (YoY) | -0.13% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 6.51% |
| Float | 26.78M |
Valuation Ratios
The trailing PE ratio is 18.86.
| PE Ratio | 18.86 |
| Forward PE | n/a |
| PS Ratio | 0.90 |
| PB Ratio | 1.64 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | 6.37 |
| P/OCF Ratio | 6.31 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.88, with an EV/FCF ratio of 5.30.
| EV / Earnings | 15.70 |
| EV / Sales | 0.75 |
| EV / EBITDA | 7.88 |
| EV / EBIT | 7.99 |
| EV / FCF | 5.30 |
Financial Position
The company has a current ratio of 2.30, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.30 |
| Quick Ratio | 1.58 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.04 |
| Interest Coverage | 10.10 |
Financial Efficiency
Return on equity (ROE) is 9.06% and return on invested capital (ROIC) is 10.39%.
| Return on Equity (ROE) | 9.06% |
| Return on Assets (ROA) | 6.73% |
| Return on Invested Capital (ROIC) | 10.39% |
| Return on Capital Employed (ROCE) | 16.92% |
| Weighted Average Cost of Capital (WACC) | 7.26% |
| Revenue Per Employee | 20.57M |
| Profits Per Employee | 983,938 |
| Employee Count | 224 |
| Asset Turnover | 1.15 |
| Inventory Turnover | 2.75 |
Taxes
In the past 12 months, IBL HealthCare has paid 180.85 million in taxes.
| Income Tax | 180.85M |
| Effective Tax Rate | 45.07% |
Stock Price Statistics
The stock price has decreased by -14.06% in the last 52 weeks. The beta is 0.45, so IBL HealthCare's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -14.06% |
| 50-Day Moving Average | 46.74 |
| 200-Day Moving Average | 50.99 |
| Relative Strength Index (RSI) | 36.37 |
| Average Volume (20 Days) | 98,331 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IBL HealthCare had revenue of PKR 4.61 billion and earned 220.40 million in profits. Earnings per share was 2.24.
| Revenue | 4.61B |
| Gross Profit | 1.64B |
| Operating Income | 433.10M |
| Pretax Income | 401.26M |
| Net Income | 220.40M |
| EBITDA | 439.42M |
| EBIT | 433.10M |
| Earnings Per Share (EPS) | 2.24 |
Balance Sheet
The company has 727.18 million in cash and 26.59 million in debt, with a net cash position of 700.60 million or 7.11 per share.
| Cash & Cash Equivalents | 727.18M |
| Total Debt | 26.59M |
| Net Cash | 700.60M |
| Net Cash Per Share | 7.11 |
| Equity (Book Value) | 2.54B |
| Book Value Per Share | 25.95 |
| Working Capital | 1.92B |
Cash Flow
In the last 12 months, operating cash flow was 659.20 million and capital expenditures -5.90 million, giving a free cash flow of 653.31 million.
| Operating Cash Flow | 659.20M |
| Capital Expenditures | -5.90M |
| Depreciation & Amortization | 6.31M |
| Net Borrowing | -135.04M |
| Free Cash Flow | 653.31M |
| FCF Per Share | 6.63 |
Margins
Gross margin is 35.70%, with operating and profit margins of 9.40% and 4.78%.
| Gross Margin | 35.70% |
| Operating Margin | 9.40% |
| Pretax Margin | 8.71% |
| Profit Margin | 4.78% |
| EBITDA Margin | 9.54% |
| EBIT Margin | 9.40% |
| FCF Margin | 14.18% |
Dividends & Yields
IBL HealthCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.01% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.13% |
| Shareholder Yield | 0.13% |
| Earnings Yield | 5.30% |
| FCF Yield | 15.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 7, 2025. It was a forward split with a ratio of 1.15.
| Last Split Date | Oct 7, 2025 |
| Split Type | Forward |
| Split Ratio | 1.15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |